|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1994-2-7
|
|
pubmed:abstractText |
Invasive adenovirus infection is recognized as an unusual cause of serious end-organ sequelae following BMT. Because symptomatic therapy may be inadequate for more serious infections, the use of investigational agents is justified. We describe a case of severe, progressive nephritis secondary to adenovirus serotype 11 following BMT. Treatment with i.v. ribavirin led to prompt clinical improvement and resolution of adenovirus excretion.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0268-3369
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
409-12
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8275042-Adenoviridae Infections,
pubmed-meshheading:8275042-Adult,
pubmed-meshheading:8275042-Bone Marrow Transplantation,
pubmed-meshheading:8275042-Cystitis,
pubmed-meshheading:8275042-Graft vs Host Disease,
pubmed-meshheading:8275042-Hemorrhage,
pubmed-meshheading:8275042-Humans,
pubmed-meshheading:8275042-Immunocompromised Host,
pubmed-meshheading:8275042-Leukemia-Lymphoma, Adult T-Cell,
pubmed-meshheading:8275042-Male,
pubmed-meshheading:8275042-Nephritis,
pubmed-meshheading:8275042-Ribavirin,
pubmed-meshheading:8275042-Salvage Therapy
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Severe adenoviral nephritis following bone marrow transplantation: successful treatment with intravenous ribavirin.
|
|
pubmed:affiliation |
Fred Hutchinson Cancer Research Center, Seattle, WA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Case Reports
|
